Job grade: AD08 Internal job grade and Interagency: AD08 and above Type of position: Temporary agent Selection procedure reference: EMA/AD/11219 Job title: Senior Environmental Risk Assessment Specialist Talent Pool: AD08 Science & Regulation Deadline for applications:
LyondellBasell is a leader in the global chemical industry creating solutions for everyday sustainable living. With a nearly 70-year legacy that includes a Nobel Prize in Chemistry and our proprietary MoReTec recycling technology, LYB is enabling
Location: Wageningen, Netherlands Hybrid: 5 days per week in the office Start date: September 2026 Duration: 6 months About the role We are looking for a motivated, analytical, and detail-oriented QFS Intern to join our Food
Location: Wageningen, Netherlands Hybrid About the position The Manager Food Safety & Scientific Risk Assessment is a key partner to R&D and Innovation teams, applying scientific expertise to ensure safe product development and ingredient introduction. This
Al 75 jaar werken de medewerkers van Charles River samen om te helpen bij het ontdekken, ontwikkelen en veilig maken van nieuwe geneesmiddelen. Wanneer u bij onze familie komt, heeft u een belangrijke impact op de gezondheid
Company Description Would you like to join an internship at a Coffee & Tea company that values your future success and prioritizes your passion for positive change? Check out this internship starting September 2026 and
Company Description Would you like to join an internship at a Coffee & Tea company that values your future success and prioritizes your passion for positive change? Check out this internship starting September 2026 and Unleash
Work ScheduleStandard (Mon-Fri) Environmental ConditionsOffice Job Description Join Us as Principal Pharmacokineticist – Make an Impact at the Forefront of Innovation We have successfully supported the top 50 pharmaceutical companies and more than 750 biotechs, spanning
XtRNA Bio is a pioneering biotechnology company developing a proprietary tRNA therapeutic platform for underserved patients with rare genetic diseases and high unmet medical needs. XtRNA Bio is advancing a novel approach to correct translational defects